Dilantin-125 (Phenytoin) - Summary

DILANTIN-125 SUMMARY

Dilantin-125^®
(Phenytoin Oral Suspension, USP)
(NOT FOR PARENTERAL USE)

Dilantin (phenytoin) is related to the barbiturates in chemical structure, but has a five-membered ring. Phenytoin is an antiepileptic drug which can be useful in the treatment of epilepsy.

Dilantin (phenytoin) is indicated for the control of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures.

Phenytoin serum level determinations may be necessary for optimal dosage adjustments (see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY sections).

DILANTIN-125 NEWS HIGHLIGHTS

Published Studies Related to Dilantin-125 (Phenytoin)

Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients. [2008]

Topical phenytoin solution for treating pressure ulcers: a prospective, randomized, double-blind clinical trial. [2007.11]

Phenytoin as an augmentation for SSRI failures: a small controlled study. [2006.11]

Sodium valproate vs phenytoin in status epilepticus: a pilot study. [2006.07.25]

Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. [2006.06]

more>>

Clinical Trials Related to Dilantin-125 (Phenytoin)

Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg [Completed]

Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study [Terminated]

Phenytoin as a Neuroprotective Agent Against Corticosteroid-Induced Functional Imaging Changes [Recruiting]

Phenytoin as an Augmentation for SSRI Failures [Completed]

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy. [Completed]

more>>